Skip to main content
Premium Trial:

Request an Annual Quote

James Posada, Gabriele Neumann

Znomics has retained James Posada effective immediately as a business advisor, the company announced this week.
Posada was previously senior vice president for business and market development at Dartmouth University spin-out Glycofi, which was subsequently acquired by Merck.
Prior to Glycofi, Posada served as senior director for business development at Protein Design Labs, manager of a therapeutic protein division at Eli Lilly, and assistant professor of biophysics and molecular biology at the University of Vermont Medical School.

BioTek Instruments this week announced that it has hired Gabriele Neumann as its European contract sales manager based in Germany.
Neumann previously held a variety of positions at Berthold Detection Systems, including technical product manager and sales product management. Most recently, she was responsible for OEM customers, worldwide distributors, and customer support.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.